Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid-19.
Manuel CappellariA ZiniD SangalliA CavalliniM ReggianiF N SepeNicola RifinoG GiussaniD GuidettiM ZeddeS MarcheselliM LongoniSimone BerettaV SidotiD M PapurelloA GiossiP NenciniM PloccoM BalestrinoEugenia RotaD ToniPublished in: European journal of neurology (2020)
Intravenous thrombolysis for patients with stroke and Covid-19 was not a rare event in the most affected areas by pandemic, and rates of 1-month unfavorable outcomes were high compared to previous data from the pre-Covid-19 literature. However, risk of sICH was not increased.
Keyphrases
- coronavirus disease
- sars cov
- pulmonary embolism
- respiratory syndrome coronavirus
- acute ischemic stroke
- systematic review
- atrial fibrillation
- high dose
- type diabetes
- stem cells
- big data
- adipose tissue
- electronic health record
- machine learning
- mesenchymal stem cells
- blood brain barrier
- low dose
- deep learning
- skeletal muscle
- weight loss